Compare LOCL & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LOCL | BDSX |
|---|---|---|
| Founded | 2021 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Precision Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.0M | 53.0M |
| IPO Year | N/A | 2020 |
| Metric | LOCL | BDSX |
|---|---|---|
| Price | $2.66 | $8.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $32.50 |
| AVG Volume (30 Days) | 20.8K | ★ 65.6K |
| Earning Date | 11-12-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $45,978,000.00 | ★ $80,173,000.00 |
| Revenue This Year | $36.93 | $20.75 |
| Revenue Next Year | $82.62 | $25.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 31.61 | 22.29 |
| 52 Week Low | $1.18 | $3.44 |
| 52 Week High | $5.75 | $32.20 |
| Indicator | LOCL | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 54.26 | 57.34 |
| Support Level | $2.27 | $7.24 |
| Resistance Level | $2.80 | $8.69 |
| Average True Range (ATR) | 0.22 | 0.65 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 74.72 | 83.84 |
Local Bounti Corp is a controlled environment agriculture company. Its business model is based on building local facilities, operated by local teams, to deliver fresh and quality produce to local communities while maintaining a limited carbon footprint. Using proprietary technology to grow leafy greens and herbs in smart greenhouses with a cultivation process that uses less water and land than conventional agriculture, free from herbicides or pesticides, it delivers products that have a longer shelf life, and are good in taste.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.